Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell membrane and associated uptake machinery constitute the primary interface between a cell and its environment, consisting of a phospholipid bilayer interspersed with various proteins such as transporters, ion channels, and receptors (Alberts et al., Molecular Biology of the Cell). This system is critical for maintaining cellular homeostasis, facilitating signal transduction, and regulating the selective entry of nutrients and ions. In a therapeutic context, this target is often addressed by drugs that either disrupt the physical integrity of the membrane or utilize specific transport pathways for cellular entry. For example, polyene antifungals like amphotericin B bind to membrane sterols to create pores, while polymyxin antibiotics interact with lipopolysaccharides in bacterial membranes to cause leakage (StatPearls, Amphotericin B; PubMed, Polymyxins). Furthermore, the uptake machinery, including endocytic pathways and solute carrier (SLC) transporters, is frequently exploited for the delivery of macromolecular drugs like antisense oligonucleotides and peptides (Nature Reviews Drug Discovery, Drug delivery across the cell membrane). Because this target encompasses a wide array of essential cellular components, drugs acting here often face challenges related to selectivity and systemic toxicity. Monitoring for biomarkers like lactate dehydrogenase release or changes in membrane potential is often necessary to assess the efficacy and safety of membrane-active agents. Overall, while not a single molecular entity, the cell membrane and its uptake systems are fundamental to the pharmacokinetics and pharmacodynamics of many clinical agents.
Direct physical disruption of the lipid bilayer, formation of transmembrane pores, or modulation of active and passive transport proteins to alter cellular permeability or facilitate drug internalization.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell membrane and associated uptake machinery.